NYSE · Health Care

STRYKER CORP SYK

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.

Medtech

Company profile

Business mix

  • It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
  • The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications.
  • The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries.
  • Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within medical devices?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 3 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 35.38 FCF 3.9% Buyback -0.15%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Fundsmith Terry Smith 7.8% $1.0B 2026-03-31
Gotham Asset Management Joel Greenblatt 0.1% $38.3M 2026-03-31
Mar Vista Investment Partners 3.4% $34.1M 2026-03-31

Recent trading changes over the last 3 quarters

Net buyers 2 Last 3 13F filing periods
Net reducers 1 Last 3 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $27.7M Estimated from net added shares
Reduction amount $530.9M Estimated from net reduced shares
Net share change / base shares -31.8% -1,531,188 / 4,812,695
Fundsmith Terry Smith 3 filing periods
13F 2025-09-30 Filed 2025-11-14
Minor reduction Shares -1.8% 13F value change -$153.1M
13F 2025-12-31 Filed 2026-02-17
Major reduction Shares -19.7% 13F value change -$401.2M
13F 2026-03-31 Filed 2026-05-15
Major reduction Shares -17.0% 13F value change -$290.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 4,677,007 Last 3 periods -1,615,591 (-34.5%) Total shares 3,061,416 Value $1.0B
Gotham Asset Management Joel Greenblatt 1 filing periods
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 129.1% 13F value change +$20.4M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 50,826 Last 3 periods +65,627 (+129.1%) Total shares 116,453 Value $38.3M
Mar Vista Investment Partners 3 filing periods
13F 2025-09-30 Filed 2025-11-12
Minor reduction Shares -2.2% 13F value change -$2.9M
13F 2025-12-31 Filed 2026-02-17
Major increase Shares 22.0% 13F value change +$4.9M
13F 2026-03-31 Filed 2026-05-13
Minor increase Shares 2.4% 13F value change -$1.5M
Settlement As of 13F 2026-03-31 · Filed 2026-05-13
Base shares 84,862 Last 3 periods +18,776 (+22.1%) Total shares 103,638 Value $34.1M

Recent mentions

No public mentions.